Log In
Print this Print this

Astrix, aspirin

  Manage Alerts
Collapse Summary General Information
Company Mayne Pharma Group Ltd.
DescriptionDelayed release pelletised form of low-dose aspirin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMyocardial infarction (MI)
Indication DetailsPrevent heart attack and stroke
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today